sponsored content

BGG supports the safety and efficacy of its CO2 Saw Palmetto Extract

5 Nov 2019

 BGG has successfully completed and published two clinical trials on its Saw Palmetto extract to support its safety and reconfirm its efficacy. 

One of the clinical trials was conducted on 44 volunteers who were given BGG’s Saw Palmetto extract or placebo over an eight-week period.  The treatment group experienced a statistically significant reduction in urinary issues versus placebo (Kushima et al., 2018).  The second clinical trial established safety at 6X the recommended dosage (Sekikawa et al., 2019).

BGG supports the safety and efficacy of its CO2 Saw Palmetto Extract

Read More